An eight-week randomised control trial in children and adolescents with obesity showed a change in microbiota (reduced number of Escherichia coli), weight and an improvement in insulin sensitivity and certain metabolic parameters after supplementation with Bifidobacterium breve BR03 and B632 [187]. Here, INS is linked to obesity disorder.